Hantavirus Confirmed Case in US by May 31: Too Close to Call

Seven days. That is the window left for another confirmed hantavirus case to land in the United States before this contract closes. The market is split almost perfectly down the middle, with YES sitting at 49 cents and NO at 52 cents. That near-even split is not indecision. It is the market pricing genuine uncertainty about a pathogen that infects irregularly, reports slowly, and leaves public health databases with notable lag.

The market question is straightforward: will another confirmed hantavirus case appear in the US by May 31, 2026? YES is priced at $0.49 and NO at $0.52, implying a 48.5% probability of YES. Total volume is just $1,368, with $746 traded in the last 24 hours. The contract closes May 31, 2026.

How the Hantavirus Confirmation Contract Works

This contract resolves YES if public health authorities confirm at least one additional hantavirus case in the United States before May 31, 2026. Resolution follows the market’s stated source. The CDC tracks hantavirus pulmonary syndrome cases through its national surveillance system, and state health departments typically report to that system with a lag of days to weeks.

• YES ($0.49, ~49%): At least one more confirmed US hantavirus case is recorded before the deadline.
• NO ($0.52, ~52%): No additional confirmed case appears in official reporting before May 31.

The NO outcome does not require hantavirus to disappear. It only requires that no new confirmation clears official channels before the deadline. Reporting lag is the real barrier here. A patient could be infected today, hospitalized this week, and still not appear in confirmed case data before May 31 if the diagnostic and reporting pipeline takes its normal course. That lag is what gives NO its slight edge.

Sponsored Partner

Market Signals and What the Thin Volume Means

The momentum composite here is essentially flat. Trend score sits at 20, hour-over-hour and day-over-day price changes are not available, and the $1,368 total volume tells you this is a lightly traded contract. Thin liquidity of $2,693 means a single informed bet of a few hundred dollars could shift the price meaningfully. This market can move sharply on new data.

The 24-hour volume of $746 against total volume of $1,368 suggests most of the trading activity has happened recently, which tracks with the contract nearing its close date. Mixed trader sentiment at roughly 49/51 confirms no strong directional conviction from either side.

Key factors shaping this market:

• Hantavirus transmission in the US is seasonal and tied to rodent population cycles, with spring and early summer representing the primary exposure window across the Four Corners region and western states.
• CDC hantavirus surveillance data runs on a reporting lag, meaning cases confirmed after May 31 for infections occurring before the deadline would not resolve this contract YES.
• No large trades have moved this market, and no single well-funded position is signaling high conviction in either direction.
• The near-50/50 split reflects genuine epidemiological uncertainty, not a mispriced contract.
• With volume below $1M, any new case confirmation or official CDC update this week could push the price by ten cents or more in minutes.

Lines Analysis: What the Hantavirus Data Actually Supports

Here’s what the measurements are telling us. The US averages roughly 20 to 40 confirmed hantavirus pulmonary syndrome cases per year, concentrated in spring and summer. The Four Corners states, New Mexico, Arizona, Colorado, and Utah, along with California and Washington, generate the bulk of cases. May falls squarely in the high-exposure season. Based on historical case frequency alone, the probability of at least one confirmed case appearing in any given week during peak season is not negligible.

The data doesn’t care about the politics, but the reporting pipeline does. What makes NO competitive is not low disease incidence. It is the gap between infection and official confirmation. The CDC requires laboratory confirmation and state health department reporting before a case enters national surveillance data. That process routinely takes one to three weeks. A case contracted this week almost certainly will not reach confirmed status before May 31. That structural lag is NO’s strongest argument.

Signals to monitor before the deadline:

• CDC hantavirus case count updates: any new confirmed case added to official surveillance data this week resolves this YES immediately.
• State health department press releases from New Mexico, Colorado, Arizona, California, or Washington: these often precede CDC database updates by days.
• Local news reports of hantavirus hospitalizations in high-incidence regions: early signal before official confirmation.
• Rodent population reports from the Four Corners region: above-average deer mouse populations in 2025 or 2026 would increase transmission risk context.
• Any CDC health advisory or alert regarding hantavirus activity: would signal elevated case activity and likely reprice YES higher.

The market is pricing uncertainty, not science. Total volume of $1,368 confirms this is a niche contract with limited participation. The epidemiological fundamentals lean YES over any given week in May, but the reporting deadline imposes a hard constraint that the base rate alone cannot overcome. The data slightly favors YES on incidence probability but slightly favors NO on reporting timeline reality.

LINES VERDICT

TOO CLOSE TO CALL

Historical case frequency says hantavirus cases are happening somewhere in the US right now. Reporting lag says confirmed data reaching official channels before May 31 is not guaranteed.

What the market says: At 48.5% implied probability, the market has landed on genuine uncertainty. With seven days left and thin liquidity, this price can shift fast if any state health department or CDC update drops before the deadline.

Key unknown: The single most important catalyst is a CDC surveillance update or state health department confirmation released before May 31. If no official confirmation publishes before the deadline, NO wins by default regardless of actual infection activity.

Scientific Context: Hantavirus in the United States

Hantavirus pulmonary syndrome is transmitted through contact with infected rodents, primarily deer mice in the western US. The Four Corners region has historically recorded the highest case density. The disease carries a case fatality rate of approximately 38%, making each confirmed case a significant public health event even at low annual totals. Peak transmission season runs April through June, aligning directly with this contract’s resolution window. Annual US case counts have ranged from roughly 15 to 40 in recent years, meaning any given week in May carries a meaningful base-rate probability of at least one new infection entering the reporting pipeline.

What could move price before May 31:

• A state health department confirmation would push YES close to certainty within hours.
• A CDC hantavirus surveillance page update adding a new 2026 case would do the same.
• If the week ends with no official confirmation, NO drifts toward 70 cents or higher as the deadline becomes the binding constraint.

Is a 49% probability reasonable?

Yes. It reflects two competing realities: hantavirus cases almost certainly exist in the reporting pipeline right now, and whether confirmed data clears the May 31 deadline is genuinely uncertain.

What does the NO contract pay out on?

NO wins if no confirmed hantavirus case appears in official US public health records before May 31, 2026. Reporting lag is the primary mechanism that could produce this outcome even during active transmission season.

What single event would move this price the most?

A CDC or state health department confirmation of a new US hantavirus case published before May 31 would reprice YES to near certainty. No other event comes close in impact.

When does this contract resolve?

The contract resolves on May 31, 2026. With volume this thin, late-breaking official data releases in the final 48 hours carry outsized price impact.

Is the volume reliable enough to trust this price?

Total volume of $1,368 and liquidity of $2,693 signal a low-participation market. Prices here reflect genuine uncertainty, but a single informed trader with $500 could shift the contract price noticeably in either direction.